Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Christopher A. Viehbacher
Christopher A. Viehbacher is recorded as CEO and Board Member at Biogen Inc. (BIIB). Biogen Inc. reported in an 8-K filed November 10, 2022 that Christopher A. Viehbacher was appointed director, effective November 14, 2022. Biogen Inc. reported in an 8-K filed November 10, 2022 that Christopher A. Viehbacher was appointed President and CEO, effective November 14, 2022. The proxy statement of Biogen Inc. reports total compensation of $23,646,004 for Christopher A. Viehbacher in fiscal 2025, including a base salary of $1,727,885. Disclosed compensation is on record for 4 fiscal years. Christopher A. Viehbacher has spoken on 1 investor event across 1 company, most recently for Biogen Inc. on September 14, 2026.
“Mr. Viehbacher will succeed Michel Vounatsos as director of Biogen effective November 14, 2022 until Biogen's next annual meeting of stockholders.”
Biogen Inc. Form 8-K, filed November 10, 2022
· Read the filing
“the Board of Directors (the "Board") has completed its search for a new Chief Executive Officer ("CEO") and has appointed Christopher A. Viehbacher, age 62, to serve as President and CEO of Biogen, beginning November 14, 2022.”
Biogen Inc. Form 8-K, filed November 10, 2022
· Read the filing
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
